<div id="readability-page-1"><p>Dynamic Technology Lab Private Ltd lessened its stake in  Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 46.6% in the 2nd quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The firm owned 27,426 shares of the company's stock after selling 23,970 shares during the quarter. Dynamic Technology Lab Private Ltd's holdings in Privia Health Group were worth $631,000 at the end of the most recent reporting period.</p><p>A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. US Bancorp DE lifted its position in  Privia Health Group by 2.4% in the 1st quarter. US Bancorp DE now owns 18,487 shares of the company's stock valued at $415,000 after acquiring an additional 429 shares in the last quarter.  Bank of Montreal Can lifted its holdings in shares of  Privia Health Group by 1.9% in the second quarter. Bank of Montreal Can now owns 28,694 shares of the company's stock valued at $660,000 after purchasing an additional 543 shares in the last quarter.  CWM LLC lifted its holdings in shares of  Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after purchasing an additional 604 shares in the last quarter.  Maryland State Retirement &amp; Pension System lifted its holdings in shares of  Privia Health Group by 2.5% in the second quarter. Maryland State Retirement &amp; Pension System now owns 30,814 shares of the company's stock valued at $709,000 after purchasing an additional 763 shares in the last quarter.  Finally, MQS Management LLC boosted its position in shares of  Privia Health Group by 8.5% during the second quarter. MQS Management LLC now owns 10,167 shares of the company's stock worth $234,000 after buying an additional 795 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds. </p><div><p><span></span><span>Get <strong>Privia Health Group</strong> alerts:</span></p></div><h2>Privia Health Group Trading Up 5.3%</h2><p>Shares of PRVA opened at $23.74 on Friday. The company's fifty day simple moving average is $24.21 and its 200 day simple moving average is $22.78. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The company has a market cap of $2.92 billion, a price-to-earnings ratio of 182.63, a PEG ratio of 3.95 and a beta of 0.83. </p><p>Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The company had revenue of $213.61 million during the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%.  As a group, research analysts forecast that  Privia Health Group, Inc. will post 0.14 earnings per share for the current year. </p><h2>Wall Street Analyst Weigh In</h2><p>A number of equities analysts have weighed in on PRVA shares. Barclays upped their price target on Privia Health Group from $22.00 to $23.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Monday, November 10th. Truist Financial  restated a &#34;buy&#34; rating and set a $31.00 target price (up previously from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Citigroup  reaffirmed an &#34;outperform&#34; rating on shares of Privia Health Group in a research report on Friday, August 29th. Stephens  reiterated an &#34;overweight&#34; rating and issued a $32.00 price target on shares of Privia Health Group in a research note on Wednesday, September 24th. Finally, Piper Sandler decreased their price objective on Privia Health Group from $36.00 to $35.00 and set an &#34;overweight&#34; rating for the company in a report on Monday, August 11th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, Privia Health Group currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $30.00.</p><p><b>Check Out Our Latest Stock Report on Privia Health Group</b></p><h2>Privia Health Group Company Profile</h2> (Free Report)<p>Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.</p><h2>Read More</h2><ul><li>Five stocks we like better than Privia Health Group</li><li>Where to Find Earnings Call Transcripts</li><li>MP Materials Stock Soared After Earnings—Here’s the Real Reason</li><li>Earnings Per Share Calculator: How to Calculate EPS</li><li>Why Palantir Slide May Be a Setup for a Long-Term Opportunity</li><li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li><li>Attention Income Investors: This REIT Is on Sale</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Privia Health Group Right Now?</h2><p>Before you consider Privia Health Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.</p><p>While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

PRVA

<p>Dynamic Technology Lab Private Ltd reduced its stake in Privia Health Group, Inc. by 46.6% in the 2nd quarter, now holding 27,426 shares worth $631,000. Other institutional investors also adjusted their positions. Privia Health Group's stock is trading up 5.3%, with a market cap of $2.92 billion. Analysts have given the stock a consensus rating of 'Moderate Buy' with an average price target of $30.00.</p>

Dynamic Technology Lab Private Ltd Has $631,000 Stock Position in Privia Health Group, Inc. $PRVA